OptiBiotix Health PLC UK Investor Show attendance
29 March 2017 - 8:47PM
RNS Non-Regulatory
TIDMOPTI
OptiBiotix Health PLC
29 March 2017
OptiBiotix Health plc
("OptiBiotix" or the "Company")
UK Investor Show attendance
OptiBiotix Health plc (AIM: OPTI), a life sciences business
developing compounds to tackle obesity, high cholesterol, diabetes
and skin care, announce that they will be participating in the UK
Investor Show 2017.
The event is taking place on 1 April 2017 at the Queen Elizabeth
II Conference Centre in Westminster, London SW1P 3EE. The team will
be available from 8:30am until 5:30pm to discuss recent events for
the Company as well as their strategy for accelerating growth. The
OptiBiotix team will be at Booth 106.
For further information, please contact:
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Executive Contact via
Walbrook below
Walbrook PR Ltd Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy Mob: 07876
741 001
About OptiBiotix - www.optibiotix.com
OptiBiotix was formed in March 2012 to develop compounds which
modify the human microbiome - the collective genome of the microbes
in the body - to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial
strains, compounds and formulations, which modulate the human
microbiome and can be used as food ingredients and supplements or
active compounds for the prevention and management of human
metabolic diseases, examples of which include obesity, cholesterol
and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators
that can impact on lipid and cholesterol management, energy harvest
and appetite suppression. The development pipeline is fuelled by
its proprietary OptiScreen(R) and OptiBiotic(R) platform
technologies designed to identify metabolic pathways and compounds
that impact on human physiology and bring potential health
benefits. These platforms are applicable across a wider range of
other human diseases.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALIFSAVFIAFID
(END) Dow Jones Newswires
March 29, 2017 05:47 ET (09:47 GMT)
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Apr 2024 to May 2024
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From May 2023 to May 2024